Vilsbøll, T., Agersø, H., Krarup, T. and Holst, J.J. (2003) Similar Elimination Rates of Glucagon-Like Peptide-1 in Obese Type 2 Diabetic Patients and Healthy Subjects. Journal of Clinical Endocrinology and Metabolism, 88, 220-224.
http://dx.doi.org/10.1210/jc.2002-021053

has been cited by the following article:

• TITLE: Antidiabetic Effects of Omega-3 Polyunsaturated Fatty Acids: From Mechanism to Therapeutic Possibilities

  AUTHORS: Yuko Iwase, Noriyasu Kamei, Mariko Takeda-Morishita

  KEYWORDS: Omega-3 Polyunsaturated Fatty Acids, Diabetes, Insulin Secretion, Docosahexaenoic Acid

  JOURNAL NAME: Pharmacology & Pharmacy, Vol.6 No.3, March 24, 2015

  ABSTRACT: Diabetes mellitus (DM) is chronic disease characterized by hyperglycemia and insulin resistance caused by dysfunction of pancreatic β cells. Over the past few decades, epidemiological studies have suggested that dietary long-chain polyunsaturated fatty acids such as docosahexaenoic acid and eicosapentaenoic acid decrease the risk of metabolic diseases including DM. The mechanisms underlying the therapeutic efficacy of dietary long-chain polyunsaturated fatty acids in treating DM have been partly revealed. In this review, the authors describe the antidiabetic effects of long-chain polyunsaturated fatty acids and also discuss their possibilities as therapeutics for DM in the light of recent findings.